Scientific Information

Scientific Programme

Preconference Course on Viral respiratory infections in infants
Chairs: L. Bont, P. Manzoni

11:30-12:00

Registrations

12:00-12:10

Opening

12:10-12:20

Opening lecture: the year in review

Louis Bont, The Netherlands

12:30-14:00

First session
What neonatologists need to know about COVID

12:30-13:00

Neonatal COVID disease: an overview after two years of pandemic

Pablo Sanchez, USA

13:00-13:30

Nutrition and specific Nutrients as a protective measure for Covid-19: are there any opportunities? Which is the role of breastfeeding?

Hans van Goudoever, The Netherlands

13:30-14:00

Interactions with other viruses, including altered seasonality

Dan Weinberger, USA

14:00-14:30

Coffee Break & sponsors’ exhibition

14:30-16:00

Second session
Passive RSV immunoprophylaxis

14:30-15:00

Next generation RSV mAbs

Octavio Ramilo, USA

15:00-15:30

Nirsevimab trial results

Paolo Manzoni, Italy

15:30-16:00

Long term consequences of RSV: the current state-of-the-art and the perspectives with the new mAbs

Eugenio Baraldi, Italy

16:00-17:00

Industry supported session

17:00-19:00

Third session
Maternal vaccination against respiratory pathogens

17:00-17:30

An overview and update about maternal vaccines and maternal vaccination strategies

Marta Nunes, South Africa

17:30-18:00

Maternal Pertussis vaccination during pregnancy

Scott Halperin, Canada

18:00-18:30

Maternal SARS-CoV-2 vaccination: what do we know after two years?

Paul Heath, UK

18:30-19:00

Closing remarks

09:00-09:15

Introduction and opening ceremony

Paolo Manzoni, Italy

09:15-09:40

Opening Lecture: Which are the game-changer RCTs in neonates in the last 5 years?

Neena Modi, UK

09:40-10:30

Respiratory session

09:40-10:05

Ventilatory strategies and late respiratory outcomes

Eduardo Bancalari, USA

10:05-10:30

Strategies of management for neonatal transition and acute RDS: which measurable health, long- term benefits?

Gianluca Lista, Italy

10:30-11:30

Coffee break - Exhibition

11:30-12:20

Nutrition session

11:30-11:55

Nutrition in the NICU and late outcomes

Hans Van Goudoever, The Netherlands

11:55-12:20

Milk-based bionutrient trials to improve outcomes in preterm infants: challenges and opportunities

Nick Embleton, UK

12:20-13:50

INDUSTRY SUPPORTED SESSION

13:50-15:05

Quality improvement to prevent infections and NEC – part 1

13:50-14:15

Quality improvements and their preventive effect on NEC

Neena Modi, UK

14:15-14:40

Maternal origins of neonatal infections: what do Ob-Gyns could/should do?

Bianca Masturzo, Italy

14:40-15:05

Bundles of quality improvement in neonatology: which measurable impact on infections

David Kaufman, USA

15:05-16:05

INDUSTRY SUPPORTED SESSION

16:05-17:30

Quality improvement to prevent infections and NEC – part 2

16:05-16:30

Quality improvements to contrast spreading out of MDR pathogens in neonatology

Pablo Sanchez, USA

16:30-16:55

Vertical transmission of Covid-19: does it happen? how to prevent?

Daniele De Luca, France

16:55-17:20

Neonatal and infant myocarditis by SARS-CoV-2 and Covid-19 vaccine: which is the truth?

Gerard Martin, USA

17:20-17:30

Closing

09:00-09:10

Opening

09:10-10:25

Innovation and prevention of late sensorial and neurodevelopmental negative outcomes

09:10-09:35

Can Innovation, Technology and Telemedicine in the NICU impact on late outcomes of prematurity in a measurable fashion?

Guilherme Sant’Anna, Canada

09:35-10:00

Metabolic and genetic investigations to prevent neonatal morbidity: which added value?

Alessandro Mussa, Torino

10:00-10:25

Prevention of negative late neurodevelopmental outcomes of prematurity: which evidence-based interventions

Luca A. Ramenghi, Italy

10:25-11:25

Industry supported session

11:25-12:15

Current and future options

11:25-11:50

Improving ROP outcomes: Ranibizumab vs laser

Andreas Stahl, Germany

11:50-12:15

Ten years of cord clamping in delivery room: which measurable benefits for the newborns?

Nestor Vain, Argentina

12:15-12:20

Closing ceremony

12:15-12:45

Industry supported session

May 21st, 2022

16:00-17:00

Industry supported session
The Real World Experience of Palivizumab against Respiratory Syncytial virus infection since 1998: A heritage of immunoprophylaxis

Chairs: Paolo Manzoni, Italy & Louis Bont, Netherlands
Speaker: Manuel Sanchez Luna, Spain


session supported by ASTRAZENECA
ASTRAZENECA


May 22nd, 2022

12:20-13:50

Respiratory infection in infants and the Covid-19 era

Paolo Manzoni, Italy
Speakers: Paolo Manzoni, Italy; Octavio Ramilo, USA; Louis Bont, The Netherlands

12:20-12:25

Welcome and Introduction
Few words on Rattle program and objective of symposium

Paolo Manzoni, Italy

12:25-12:45

Topic 1 – What is RSV real impact of disease and how has it been impacted during the COVID pandemic ERA?
  • Epidemiology in all infants
  • Seasonality
  • Perceptions
  • Urgency more than ever to protect all infants

Paolo Manzoni, Italy

12:45-12:50

Discussion Panel

Chair and Panel

12:50-13:10

Topic 2 – What can we learn from recent trends? And what we expect in the near future?
  • The risk of having Non interventional preventive measures (masks and quarantine) and entire naïve cohorts
  • Burden of RSV disease in the future
  • Outpatient/inpatient perspectives

Octavio Ramilo, USA

13:10-13:15

Discussion Panel

Chair and Panel

13:15-13:35

Topic 3 – Can we talk about long post-RSV infection?
  • How viral respiratory disease originate later in life sequelae
  • Comparison with post Covid
  • Wheezing, Asthma, etc from RSV

Louis Bont, The Netherlands

13:35-13:40

Discussion Panel

Chair and Panel

13:40-13:50

Question & Answer. Closing remarks

Paolo Manzoni, Italy

session supported by SANOFI

Sanofi Pasteur


15:05-16:05

Foetal Growth, Metabolism, and Angiogenesis: Exploring the Critical Impact on Pulmonary and Neurological Outcomes after Extremely Preterm Birth

Speakers: Steve Abman, USA; Boris Kramer, the Netherlands

session supported by OAK HILL BIO
OAK HILL BIO


May 23rd, 2022

10:25-11:45

The Role of Nutrition in Infant Intestinal Development, Health, and Long-term Implications

-

Eubiotic and Dysbiotic State

Fayez Ghishan, USA

-

Prebiotics, Oligosaccharides, & Lactose

Yvan Vandenplas, Belgium

-

Lactoferrin & MFGM

Paolo Manzoni, Italy

session supported by BYHEART
BYHEART


12:35-13:10

Current scientific evidence on the long-term impact of Palivizumab immunoprophylaxis in infants

Chair: Paolo Manzoni, Italy
Speaker: Eugenio Baraldi, Italy


session supported by ASTRAZENECA
ASTRAZENECA


Invited Speakers

Eduardo BancalariUSA
Eugenio BaraldiItaly
Louis BontThe Netherlands
Daniele De Luca France
Nik EmbletonUK
Avroy FanaroffUSA
Scott HalperinCanada
Paul HeathUK
David KaufmanUSA
Gianluca ListaItaly
Paolo ManzoniItaly
Gerard MartinUSA
Bianca MasturzoItaly
Neena ModiUK
Marta NunesSouth Africa
Gerhard PichlerAustria*
Luca A. RamenghiItaly
Octavio RamiloUSA
Pablo SanchezUSA
Guilherme Sant’AnnaCanada
Andreas StahlGermany
Nestor VainArgentina
Hans Van GoudoeverThe Netherlands
Dan WeinbergerUSA

*pending confirmation